Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Neurology|September 17, 1999
A pilot study of MRI activity before and during interferon beta-1a therapyE Waubant, D E Goodkin, R Sloan, et al.
Archives of Neurology|September 17, 1999
Multiple sclerosis that is progressive from the time of onset: clinical characteristics and progression of disabilityP B Andersson, E Waubant, L Gee, et al.
Archives of Neurology|October 1, 1989
Cognitive disturbances in patients with relapsing remitting multiple sclerosisW W Beatty, D E Goodkin, N Monson, et al.
Brain and Cognition|September 1, 1989
Frontal lobe dysfunction and memory impairment in patients with chronic progressive multiple sclerosisW W Beatty, D E Goodkin, P A Beatty, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 1, 1997
Depression, coping and level of neurological impairment in multiple sclerosisD C Mohr, D E Goodkin, N Gatto, et al.
Neurology|February 1, 1996
Side effect profile of interferon beta-1b in MS: results of an open label trialL K Neilley, D S Goodin, D E Goodkin, et al.
Applied Nursing Research : ANR|May 1, 1996
Relationships among illness uncertainty, stress, coping, and emotional well-being at entry into a clinical drug trialN M Wineman, K M Schwetz, D E Goodkin, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|June 8, 2001
Injectable medication for the treatment of multiple sclerosis: the influence of self-efficacy expectations and injection anxiety on adherence and ability to self-injectD C Mohr, A C Boudewyn, W Likosky, et al.
Pageof 8